TBIO - Telesis Bio Inc
IEX Last Trade
3.43
0.070 2.041%
Share volume: 40,605
Last Updated: Fri 30 Aug 2024 04:53:43 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$3.36
0.07
2.08%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-11 | 2022-08-10 | 2022-11-09 | 2023-03-22 | 2023-05-12 | 2023-08-11 | 2023-11-13 | |
| Assets | ||||||||
| Total Assets | 111.134 M | 97.284 M | 88.142 M | 81.362 M | 89.162 M | 114.526 M | 105.029 M | |
| Current Assets | 87.878 M | 72.027 M | 62.185 M | 55.092 M | 42.939 M | 61.543 M | 52.713 M | |
| Inventories | 2.536 M | 1.776 M | 2.195 M | 2.200 M | 2.294 M | 3.861 M | 4.270 M | |
| Other Current Assets | 4.014 M | 3.477 M | 4.399 M | 3.288 M | 2.568 M | 1.912 M | 1.456 M | |
| Short Term Investments | 4.014 M | 3.477 M | 4.399 M | 3.288 M | 2.568 M | 1.912 M | 1.456 M | |
| Total Receivables | 4.561 M | 4.885 M | 5.661 M | 5.851 M | 5.835 M | 8.240 M | 5.358 M | |
| Current Cash | 76.767 M | 61.889 M | 49.755 M | 43.578 M | 32.067 M | 47.355 M | 41.454 M | |
| Total Non-current Assets | 23.256 M | 25.257 M | 25.957 M | 26.270 M | 46.223 M | 52.983 M | 52.316 M | |
| Property Plant Equipment | 3.968 M | 6.306 M | 6.291 M | 6.861 M | 7.256 M | 7.557 M | 7.364 M | |
| Other Assets | 2.674 M | 2.481 M | 2.769 M | 2.641 M | 22.327 M | 28.915 M | 28.570 M | |
| Intangible Assets | 2.284 M | 2.140 M | 2.011 M | 1.882 M | 1.754 M | 1.625 M | 1.496 M | |
| Goodwill | 14.330 M | 14.330 M | 14.886 M | 14.886 M | 14.886 M | 14.886 M | 14.886 M | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 111.134 M | 97.284 M | 88.142 M | 81.362 M | 89.162 M | 114.526 M | 105.029 M | |
| Total liabilities | 33.034 M | 32.564 M | 34.834 M | 34.797 M | 52.543 M | 58.457 M | 58.540 M | |
| Total current liabilities | 16.023 M | 18.244 M | 12.808 M | 13.498 M | 11.240 M | 10.386 M | 25.419 M | |
| Accounts Payable | 3.853 M | 3.870 M | 1.617 M | 1.295 M | 2.439 M | 1.430 M | 2.399 M | |
| Other liabilities | 3.284 M | 2.359 M | 1.382 M | 509.000 K | 361.000 K | 357.000 K | 159.000 K | |
| Current long term debt | 3.322 M | 4.839 M | 733.000 K | 637.000 K | 774.000 K | 1.549 M | 16.954 M | |
| Long term debt | 13.727 M | 11.961 M | 20.644 M | 20.790 M | 40.942 M | 47.714 M | 32.962 M | |
| Other liabilities | 3.284 M | 2.359 M | 1.382 M | 509.000 K | 361.000 K | 357.000 K | 159.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 78.100 M | 64.720 M | 53.308 M | 46.565 M | 36.619 M | 56.069 M | 46.489 M | |
| Common stock | 29.331 M | 29.436 M | 29.519 M | 29.567 M | 29.663 M | 29.774 M | 29.947 M | |
| Retained earnings | -78.464 M | -93.295 M | -105.609 M | -113.741 M | -124.860 M | -133.147 M | -143.778 M |